« Previous
Next »
Academic Radiology
Volume 17, Issue 11
, Pages 1394-1400
, November 2010
Comparison of Gadofosveset Trisodium and Gadobenate Dimeglumine During Time-Resolved Thoracic MR Angiography at 3T
References
- Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005;40:715–724
- . Rationale and applications for macromolecular Gd-based contrast agents. Magn Reson Med. 1991;22:282–287
- MS-325: a small-molecule vascular imaging agent for magnetic resonance imaging. Acad Radiol. 1996;3(suppl):S356–S358
- MR angiography with gadofosveset trisodium for peripheral vascular disease: phase II trial. Radiology. 2003;229:811–820
- Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography—multicenter comparative phase III study. Radiology. 2005;236:71–78
- Carotid MR angiography: phase II study of safety and efficacy for MS-325. Radiology. 2001;219:114–122
- First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine. Invest Radiol. 2007;42:659–664
- Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med. 1996;36:345–351
- 3D time-resolved MR angiography (MRA) of the carotid arteries with time-resolved imaging with stochastic trajectories: comparison with 3D contrast-enhanced bolus-chase MRA and 3D time-of-flight MRA. AJNR Am J Neuroradiol. 2008;29:1847–1854
- 4D time-resolved MR angiography with keyhole (4D-TRAK): more than 60 times accelerated MRA using a combination of CENTRA, keyhole, and SENSE at 3.0T. J Magn Reson Imaging. 2008;27:1455–1460
- Whole-body MR angiography with body coil acquisition at 3 T in patients with peripheral arterial disease using the contrast agent gadofosveset trisodium. Acad Radiol. 2009;16:654–661
- First-pass and steady-state magnetic resonance angiography of the thoracic vasculature using gadofosveset trisodium. J Magn Reson Imaging. 2009;30:809–816
- Thoracic and abdominal MRA with gadofosveset: influence of injection rate on vessel signal and image quality. Eur Radiol. 2009;19:1932–1938
- Highly accelerated first-pass contrast-enhanced magnetic resonance angiography of the peripheral vasculature: comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents. J Magn Reson Imaging. 2009;30:1085–1092
- Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: comparison of gadobenate dimeglumine and gadofosveset trisodium. Eur J Radiol. 2009;[Epub ahead of print]
- Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med. 2002;47:1202–1210
- . Parallel imaging at high field strength: synergies and joint potential. Top Magn Reson Imaging. 2004;15:237–244
- Practical approaches to the evaluation of signal-to-noise ratio performance with parallel imaging: application with cardiac imaging and a 32-channel cardiac coil. Magn Reson Med. 2005;54:748–754
- . Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol Imaging. 2006;1:128–137
- Binding of gadobenate dimeglumine to proteins extravasated into interstitial space enhances conspicuity of reperfused infarcts. Invest Radiol. 1994;29(suppl):S50–S53
- Variable echo time imaging: signal characteristics of 1-M gadobutrol contrast agent at 1.5 and 3T. Magn Reson Med. 2008;59:113–123
Dr Markl receives funding from Deutsche Forschungsgemeinschaft (Bonn, Germany; grant MA 2383/4-1) and Bundesministerium für Bildung und Forschung (Bonn, Germany; grant 01EV0706).
PII: S1076-6332(10)00313-2
doi: 10.1016/j.acra.2010.05.022
© 2010 AUR. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Academic Radiology
Volume 17, Issue 11
, Pages 1394-1400
, November 2010
